Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes MellitusScheen, André J.Drugs (New York, N.Y.), 2015-01, Vol.75 (1), p.33-59 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
2 |
Material Type: Artigo
|
Pharmacokinetic and Pharmacodynamic Profile of Empagliflozin, a Sodium Glucose Co-Transporter 2 InhibitorScheen, André J.Clinical pharmacokinetics, 2014-03, Vol.53 (3), p.213-225 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
3 |
Material Type: Artigo
|
Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney DiseaseScheen, André J.Clinical pharmacokinetics, 2020-08, Vol.59 (8), p.981-994 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
4 |
Material Type: Artigo
|
Canagliflozin: A Review in Type 2 DiabetesDeeks, Emma D. ; Scheen, André J.Drugs (New York, N.Y.), 2017-09, Vol.77 (14), p.1577-1592 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
5 |
Material Type: Artigo
|
Pharmacokinetics and Clinical Use of Incretin-Based Therapies in Patients with Chronic Kidney Disease and Type 2 DiabetesScheen, André J.Clinical pharmacokinetics, 2015-01, Vol.54 (1), p.1-21 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
6 |
Material Type: Artigo
|
Dipeptidylpeptitase-4 Inhibitors (Gliptins): Focus on Drug-Drug InteractionsSCHEEN, André JClinical Pharmacokinetics, 2010-09, Vol.49 (9), p.573-588 [Periódico revisado por pares]Auckland: Adis InternationalTexto completo disponível |
|
7 |
Material Type: Artigo
|
Drug–Drug Interactions with Sodium-Glucose Cotransporters Type 2 (SGLT2) Inhibitors, New Oral Glucose-Lowering Agents for the Management of Type 2 Diabetes MellitusScheen, André J.Clinical pharmacokinetics, 2014-04, Vol.53 (4), p.295-304 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
8 |
Material Type: Artigo
|
Pharmacokinetic Characteristics and Clinical Efficacy of an SGLT2 Inhibitor Plus DPP-4 Inhibitor Combination Therapy in Type 2 DiabetesScheen, André J.Clinical pharmacokinetics, 2017-07, Vol.56 (7), p.703-718 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
9 |
Material Type: Artigo
|
2D-Cosy NMR Spectroscopy as a Quantitative Tool in Biological Matrix: Application to CyclodextrinsDufour, Gilles ; Evrard, Brigitte ; de Tullio, PascalThe AAPS journal, 2015-11, Vol.17 (6), p.1501-1510 [Periódico revisado por pares]New York: Springer USTexto completo disponível |
|
10 |
Material Type: Artigo
|
Nanoparticles: Oral Delivery for Protein and Peptide DrugsCao, Shu-jun ; Xu, Shuo ; Wang, Hui-ming ; Ling, Yong ; Dong, Jiahua ; Xia, Rui-dong ; Sun, Xiang-hongAAPS PharmSciTech, 2019-05, Vol.20 (5), p.190 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |